BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 83 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,180,760 | -57.6% | 81,940 | -51.7% | 0.00% | -100.0% |
Q2 2023 | $2,783,484 | -6.8% | 169,523 | -5.2% | 0.00% | 0.0% |
Q1 2023 | $2,986,256 | +10.6% | 178,771 | +2.2% | 0.00% | 0.0% |
Q4 2022 | $2,700,000 | +3.6% | 175,008 | +0.3% | 0.00% | 0.0% |
Q3 2022 | $2,605,000 | -4.8% | 174,521 | +4.9% | 0.00% | 0.0% |
Q2 2022 | $2,736,000 | +87.8% | 166,438 | +127.3% | 0.00% | – |
Q1 2022 | $1,457,000 | +17.5% | 73,217 | +49.8% | 0.00% | – |
Q4 2021 | $1,240,000 | +62.1% | 48,885 | +72.3% | 0.00% | – |
Q3 2021 | $765,000 | +15.9% | 28,364 | +24.3% | 0.00% | – |
Q2 2021 | $660,000 | -78.9% | 22,818 | -80.9% | 0.00% | -100.0% |
Q1 2021 | $3,126,000 | +4.7% | 119,406 | +14.5% | 0.00% | 0.0% |
Q4 2020 | $2,987,000 | -10.0% | 104,253 | -25.1% | 0.00% | 0.0% |
Q3 2020 | $3,320,000 | +21.9% | 139,204 | +5.6% | 0.00% | 0.0% |
Q2 2020 | $2,724,000 | – | 131,867 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
Matisse Capital | 51,296 | $739,175 | 0.52% |
Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |